Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1330198rdf:typepubmed:Citationlld:pubmed
pubmed-article:1330198lifeskim:mentionsumls-concept:C1533685lld:lifeskim
pubmed-article:1330198lifeskim:mentionsumls-concept:C0221464lld:lifeskim
pubmed-article:1330198lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:1330198lifeskim:mentionsumls-concept:C0947677lld:lifeskim
pubmed-article:1330198pubmed:issue9lld:pubmed
pubmed-article:1330198pubmed:dateCreated1992-12-3lld:pubmed
pubmed-article:1330198pubmed:abstractTextThirteen patients undergoing selective coeliac angiography before insertion of an indwelling hepatic arterial cannula underwent injection of 3 ml radiolabelled Lipiodol (2 MBq 131I) into the hepatic artery at the end of the procedure. At subsequent laparotomy 1-9 days later, biopsies were taken from normal liver and metastases. The radioactivity of this material was measured to establish the tumour:liver ratios. Two patients with large metastases (> 10 cm in diameter) had low ratios. In the remainder, the median ratio at 24 h was 1.5:1 (range 1.1-2.5:1; n = 5) and 2.6:1 (range 1.5-64.0:1; n = 6) at 3-9 days. Four patients underwent single photon emission computed tomography, which confirmed selective retention of Lipiodol in small metastases, although no activity was detected in a large deposit (> 15 cm) 10 days after injection. The tumour:liver ratio in the other three patients increased from 3.0-5.6:1 on day 1 to 4.5-7.2:1 on day 6. This study suggests that Lipiodol may be a useful therapeutic delivery agent to small colorectal liver metastases.lld:pubmed
pubmed-article:1330198pubmed:languageenglld:pubmed
pubmed-article:1330198pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1330198pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1330198pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1330198pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1330198pubmed:statusMEDLINElld:pubmed
pubmed-article:1330198pubmed:monthSeplld:pubmed
pubmed-article:1330198pubmed:issn0007-1323lld:pubmed
pubmed-article:1330198pubmed:authorpubmed-author:FlemingJJlld:pubmed
pubmed-article:1330198pubmed:authorpubmed-author:TaylorIIlld:pubmed
pubmed-article:1330198pubmed:authorpubmed-author:BirchSSlld:pubmed
pubmed-article:1330198pubmed:authorpubmed-author:ILESP APAlld:pubmed
pubmed-article:1330198pubmed:authorpubmed-author:BattiFFlld:pubmed
pubmed-article:1330198pubmed:authorpubmed-author:LoizidouMMlld:pubmed
pubmed-article:1330198pubmed:authorpubmed-author:PerringSSlld:pubmed
pubmed-article:1330198pubmed:issnTypePrintlld:pubmed
pubmed-article:1330198pubmed:volume79lld:pubmed
pubmed-article:1330198pubmed:ownerNLMlld:pubmed
pubmed-article:1330198pubmed:authorsCompleteYlld:pubmed
pubmed-article:1330198pubmed:pagination952-4lld:pubmed
pubmed-article:1330198pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1330198pubmed:meshHeadingpubmed-meshheading:1330198-...lld:pubmed
pubmed-article:1330198pubmed:meshHeadingpubmed-meshheading:1330198-...lld:pubmed
pubmed-article:1330198pubmed:meshHeadingpubmed-meshheading:1330198-...lld:pubmed
pubmed-article:1330198pubmed:meshHeadingpubmed-meshheading:1330198-...lld:pubmed
pubmed-article:1330198pubmed:meshHeadingpubmed-meshheading:1330198-...lld:pubmed
pubmed-article:1330198pubmed:meshHeadingpubmed-meshheading:1330198-...lld:pubmed
pubmed-article:1330198pubmed:year1992lld:pubmed
pubmed-article:1330198pubmed:articleTitleBiodistribution of Lipiodol following hepatic arterial injection.lld:pubmed
pubmed-article:1330198pubmed:affiliationUniversity Surgical Unit, Southampton General Hospital, UK.lld:pubmed
pubmed-article:1330198pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1330198lld:pubmed